Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-06

Clinical Trial Update: Construct Validity and Responsiveness of EQ-5D-3L in Patients With Rheumatic Disease

View source ↗

Summary

A completed study evaluating the construct validity and responsiveness of the EQ-5D-3L health-status instrument in patients with rheumatic diseases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Karolinska Institutet | Conditions: Rheumatoid Arthritis, Polyarthritis | Status: COMPLETED